Dr. Scott Lippman

Writer

Recent Articles

  • Frontline Cancer: Moving to better serve Hispanic patients

    Frontline Cancer: Moving to better serve Hispanic patients

    Like California in general, the counties of San Diego and Imperial are “majority-minority,” a demographics term that means the majority of the population is comprised of non-white groups. The largest of these groups is Hispanic/Latino, currently numbering approximately 1.2 million persons in the...

  • Frontline Cancer: Thoughts for Prostate Cancer Awareness Month

    Frontline Cancer: Thoughts for Prostate Cancer Awareness Month

    • FRONTLINE CANCER: Prostate cancer is the most common cancer in American men after skin cancer, with roughly 221,000 new cases each year. But while this number is high, the prognosis is pretty good: Virtually all men diagnosed with prostate cancer will survive five years or more if the disease...

  • FRONTLINE CANCER: Son’s cancer diagnosis brings home doctor's mission to find a cure

    FRONTLINE CANCER: Son’s cancer diagnosis brings home doctor's mission to find a cure

    Editor’s Note: Last week, I received this beautiful letter from contributing columnist, Dr. Scott Lippman, director of the UC San Diego Moores Cancer Center. With his permission, I’m sharing it here with our valued readers. We invite you to join the La Jolla Light staff in supporting the efforts...

  • FRONTLINE CANCER: New cancer cell initiative maps mutations

    FRONTLINE CANCER: New cancer cell initiative maps mutations

    When the first draft of the human genome project was published in 2001, it justifiably sparked much acclaim and anticipation. It marked a new era in science, one fraught with expectation, not least of which was that the revealed genetic code would, in time, lead to new therapies for treating myriad...

  • FRONTLINE CANCER: Cancer Survivor rates continue to improve

    FRONTLINE CANCER: Cancer Survivor rates continue to improve

    June is National Cancer Survivor Month, highlighted by National Cancer Survivors Day, which occurred June 7. At University of California, San Diego Moores Cancer Center, we marked this 28th annual celebration with a week’s worth of events intended to honor both patients who have survived their...

  • FRONTLINE CANCER: Fighting liver cancer, Part 2

    FRONTLINE CANCER: Fighting liver cancer, Part 2

    Second of two parts. Untreated, hepatocellular carcinoma (HCC) — or what people more commonly call liver cancer — is quickly fatal, usually within a year or so. Traditional chemotherapy does little to control the disease. Surgery to remove a tumor can provide a local cure, but it does nothing to...

  • FRONTLINE CANCER: Fighting liver cancer, Part 1

    FRONTLINE CANCER: Fighting liver cancer, Part 1

    Among the myriad of malignancies that plague us, liver cancer doesn’t generally register. It’s not among the top 10 cancers in the United States. It doesn’t get the same media attention as prostate, breast or lung cancers that, along with colon and pancreas, constitute the nation’s deadliest cancers....

  • Frontline Cancer: Examining the luck factor

    Frontline Cancer: Examining the luck factor

    • FRONTLINE CANCER: Some of you may have read news stories recently that suggested getting cancer is simply a matter of bad luck, and that nothing can be done to significantly reduce one’s cancer risk. This conclusion is based upon a study conducted by researchers at Johns Hopkins University and...

1234 5
69°